| Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019 S Gillessen, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, A Briganti, ... European urology 77 (4), 508-547, 2020 | 355 | 2020 |
| Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: a report of 3328 patients (HKNPCSG 1301 study) KH Au, RKC Ngan, AWY Ng, DMC Poon, WT Ng, KT Yuen, VHF Lee, ... Oral oncology 77, 16-21, 2018 | 250 | 2018 |
| Analysis of plasma Epstein-Barr virus DNA in nasopharyngeal cancer after chemoradiation to identify high-risk patients for adjuvant chemotherapy: a randomized controlled trial ATC Chan, EP Hui, RKC Ngan, SY Tung, ACK Cheng, WT Ng, VHF Lee, ... Journal of clinical oncology, 2018 | 213 | 2018 |
| Management of hepatocellular carcinoma with portal vein tumor thrombosis: review and update at 2016 SL Chan, CCN Chong, AWH Chan, DMC Poon, KSH Chok World journal of gastroenterology 22 (32), 7289, 2016 | 180 | 2016 |
| An international collaborative consensus statement on en bloc resection of bladder tumour incorporating two systematic reviews, a two-round Delphi survey, and a consensus meeting JYC Teoh, S MacLennan, VWS Chan, J Miki, HY Lee, E Chiong, LS Lee, ... European urology 78 (4), 546-569, 2020 | 107 | 2020 |
| Radiomics feature reliability assessed by intraclass correlation coefficient: a systematic review C Xue, J Yuan, GG Lo, ATY Chang, DMC Poon, OL Wong, Y Zhou, ... Quantitative imaging in medicine and surgery 11 (10), 4431, 2021 | 78 | 2021 |
| Integrating postradiotherapy plasma Epstein–Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy EP Hui, WF Li, BB Ma, WKJ Lam, KCA Chan, F Mo, QYH Ai, AD King, ... Annals of Oncology 31 (6), 769-779, 2020 | 67 | 2020 |
| Management of patients with advanced prostate cancer: report from the Advanced Prostate Cancer Consensus Conference 2021 S Gillessen, A Armstrong, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, ... European urology 82 (1), 115-141, 2022 | 64 | 2022 |
| Head and neck tumors: amide proton transfer MRI BKH Law, AD King, QY Ai, DMC Poon, W Chen, KS Bhatia, AT Ahuja, ... Radiology 288 (3), 782-790, 2018 | 58 | 2018 |
| Abiraterone acetate in metastatic castration-resistant prostate cancer–the unanticipated real-world clinical experience DMC Poon, K Chan, SH Lee, TW Chan, H Sze, EKC Lee, D Lam, ... BMC urology 16, 1-10, 2016 | 56 | 2016 |
| Management of patients with advanced prostate cancer. Part I: intermediate-/high-risk and locally advanced disease, biochemical relapse, and side effects of hormonal treatment … S Gillessen, A Bossi, ID Davis, J de Bono, K Fizazi, ND James, N Mottet, ... European urology 83 (3), 267-293, 2023 | 52 | 2023 |
| Extranodal extension is a criterion for poor outcome in patients with metastatic nodes from cancer of the nasopharynx QY Ai, AD King, DMC Poon, FKF Mo, EP Hui, M Tong, AT Ahuja, BBY Ma, ... Oral Oncology 88, 124-130, 2019 | 50 | 2019 |
| Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion-weighted MRI QY Ai, AD King, JSM Chan, W Chen, KCA Chan, JKS Woo, BCY Zee, ... European Radiology 29, 5627-5634, 2019 | 44 | 2019 |
| Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC … S Gillessen, A Bossi, ID Davis, J de Bono, K Fizazi, ND James, N Mottet, ... European Journal of Cancer 185, 178-215, 2023 | 37 | 2023 |
| Convolutional neural network for discriminating nasopharyngeal carcinoma and benign hyperplasia on MRI LM Wong, AD King, QYH Ai, WKJ Lam, DMC Poon, BBY Ma, KCA Chan, ... European radiology 31, 3856-3863, 2021 | 33 | 2021 |
| Patterns of care and treatment outcomes for local recurrence of NPC after definite IMRT—A study by the HKNPCSG WT Ng, ECY Wong, AKW Cheung, JCH Chow, DMC Poon, JWY Lai, ... Head & neck 41 (10), 3661-3669, 2019 | 31 | 2019 |
| Risk of newonset diabetes after androgen deprivation therapy for prostate cancer in the A sian population: 亚洲前列腺癌患者接受雄激素去势治疗后患糖尿病的风险分析 JYC Teoh, PKF Chiu, SYS Chan, DMC Poon, HY Cheung, SSM Hou, ... Journal of diabetes 7 (5), 672-680, 2015 | 28 | 2015 |
| Importance of cycles of chemotherapy and postdocetaxel novel therapies in metastatic castration-resistant prostate cancer DMC Poon, J Ng, K Chan Prostate International 3 (2), 51-55, 2015 | 26 | 2015 |
| Reliability of MRI radiomics features in MRguided radiotherapy for prostate cancer: repeatability, reproducibility, and withinsubject agreement C Xue, J Yuan, DMC Poon, Y Zhou, B Yang, SK Yu, YK Cheung Medical Physics 48 (11), 6976-6986, 2021 | 24 | 2021 |
| Risk of cardiovascular thrombotic events after surgical castration versus gonadotropin-releasing hormone agonists in Chinese men with prostate cancer JYC Teoh, SYS Chan, PKF Chiu, DMC Poon, HY Cheung, SSM Hou, ... Asian Journal of Andrology 17 (3), 493-496, 2015 | 23 | 2015 |
